CDMO PharmaLogic expands deal with radiopharma specialist Ratio

Mar 18, 2024 · BMS-backed radiopharma specialist Ratio expands manufacturing deal with CDMO PharmaLogic. By Kevin Dunleavy Mar 18, 2024 9:27am. radiopharmaceuticals Merck …

CouponFollow Extension

$50000000
OFF

Series B - Ratio Therapeutics - 2024-01-17 - Crunchbase

6 days from now

Jan 17, 2024 · Ratio Therapeutics raised $50000000 on 2024-01-17 in Series B. Search Crunchbase. Start Free Trial . ... Fierce Pharma — BMS-backed radiopharma specialist Ratio …

crunchbase.com

$102
OFF

EQT Leads $102M Investment For Radiopharma Manufacturer PanTera

6 days from now

Sep 11, 2024 · BMS-backed radiopharma specialist Ratio expands manufacturing deal with CDMO PharmaLogic. As many companies are scaling up for clinical trials, demand for 225-Ac …

fiercepharma.com

2%
OFF

Radiopharmaceuticals: A Niche But Growing Sector

6 days from now

2 days ago · The global radiopharmaceuticals market was estimated at $5.97 billion in 2023 and is expected to increase at a compound annual growth rate of 8.2% to reach $13.67 billion by …

dcatvci.org

FAQs about CDMO PharmaLogic expands deal with radiopharma specialist Ratio Coupon?

Which pharmaceutical companies have backed CDMO isotherapeutics & artms?

Meanwhile, Australia’s Telix Pharmaceuticals recently inked back-to-back buyouts of Texas-based CDMO IsoTherapeutics and Canada’s ARTMS Inc. Following Nucleus' 2022 debut, the GE HealthCare- and Mayo Clinic-backed radiopharmaceuticals CDMO is ready to put its production thesis to the test. ...

Does Novartis have a CDMO?

Among large drugmakers, Novartis has been at the forefront of the radiopharma field. The company's prostate cancer therapy Pluvicto won FDA approval last year and has been rapidly growing sales. But, along the way, the company had to pause new patient starts to get a handle on manufacturing issues. RLS Radiopharmacies is adding a CDMO capability. ...

What's going on with the CDMO & artbio?

Last October, the CDMO ginned up an oversubscribed, $56 million, series A investment round led by Eclipse and GE HealthCare, which Nucleus said it would use to fund new facilities in the U.S. ARTBIO, for its part, launched last summer. ...

How big is the radiopharmaceutical market?

The radiopharmaceutical market is expected to grow from $7 billion this year to $39 billion by 2032. Two years into its existence, radioisotope producer PanTera has drawn 93 million euros ($102.5 million) in a Series A investment round. ...

Can radiopharmaceuticals treat solid tumors?

At the time of the deal announcement, BMS’ chief medical officer for drug development, Samit Hirawat, M.D., noted that radiopharmaceuticals represent one of the “most promising and fastest-growing” new modalities for attacking solid tumors. ...

What are radiopharmaceuticals?

Radiopharmaceuticals, also known as radiotherapies, are essentially guided radioactive drugs that can be used to help diagnose diseases in smaller amounts and treat certain cancers and other conditions in higher quantities. ...